STD Journal publishes clinical integration study on Visby PCRRead more How to Buy News A library of recent articles, news and insights. Filters: AllArticleClinical StudiesPress ReleaseRapid TestingResearch 12/01/2021 • Press Release Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association Integration of the Visby Medical sexually transmitted infections (STI) panel into clinical practice could significantly reduce over- and under-treatment of Chlamydia, Gonorrhea, and Trichomonas Read More 12/01/2021 • Clinical Studies Antimicrobial stewardship, rapid PCR and STI Significant improvement to patient care and antimicrobial stewardship with appropriate use of antibiotics may be achieved through the use of rapid point-of-care PCR STI testing. Read More 10/28/2021 • Press Release Visby Medical Appoints Industry Veteran Thomas Prescott as Chairman of the Board Thomas Prescott, former president and chief executive officer (CEO) of Align Technology and Cardiac Pathways, will join as the company’s new chairman of the board. Read More 10/21/2021 • Article Visby Medical Exhibits at ACEP21 Scientific Assembly in Boston Visit our booth on the show floor or stop by our virtual booth via the ACEP app to set an appointment to learn about our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas. Read More 10/21/2021 • Press Release Visby Medical Appoints Industry Veteran John W. Kuo as Chief Legal Officer Visby Medical™, a leading medical diagnostic company, today announced the appointment of John W. Kuo as the company’s new Chief Legal Officer. An experienced veteran in corporate law, Kuo brings more than 30 years of experience across multiple industries, including nearly 20 years in the healthcare industry. Read More 09/13/2021 • Press Release FDA Grants Emergency Use Authorization for Visby Medical’s COVID-19 RT-PCR Test for Pooled Samples The Visby Medical™ instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test was granted Emergency Use Authorization (EUA) by the FDA Read More 08/30/2021 • Press Release Visby Medical™ Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test The Visby Medical Sexual Health Click Test is the first instrument-free PCR test for the detection of Chlamydia, Gonorrhea, and Trichomonas, with results available within 30 minutes, during the patient visit. Read More 07/16/2021 • Press Release Visby Medical Makes Strategic Hires to Continue Business Development Visby Medical appoints Mark Ibison as Chief Financial Officer, Christopher J. Jowett as Chief Commercial Officer, and Alicia Zuiker as Chief People Officer Read More 06/23/2021 • Article COVID-19 Testing: Its Role in Safely Reopening The global COVID-19 pandemic touches and disrupts every aspect of life and livelihood across geographies. Despite progress with public health practices and vaccinations, our personal and professional futures face uncertainty. Inconsistent and ambiguous re-opening procedures hinder a robust return to pre-pandemic routines that can restore productivity and economic health. Read More 04/22/2021 • Rapid Testing Will COVID Testing Be Needed When the Pandemic Ends? With the COVID-19 vaccine being distributed and overall infection rates stabilizing, people are beginning to talk about life after the pandemic. Anxious to get back to some kind of normality, even if it means adopting a new normal that includes continued mask wearing and physical distancing, businesses are making plans to open back up. Read More 02/02/2021 • Press Release Visby Medical’s COVID-19 PCR Point of Care Test Authorized for Use in CLIA Waived Settings Expanding critical access to the only single-use, rapid PCR test, at the point of care. Read More 02/02/2021 • Press Release Visby Medical speeds development of a rapid Flu-COVID PCR test designed for at-home use with BARDA funding Visby Medical pairs speed with the accuracy of gold-standard PCR testing in a single-use device, so doctors don’t have to fight blind. Read More 11/23/2020 • Research Lancet publishes paper on the Visby Medical point-of-care PCR technology A study of the performance of the Visby Medical Sexual Health Test, a single-use, point-of-care PCR device. Read More 10/07/2020 • Article What is PCR? PCR’s superpower lies in its super sensitivity, which enables it to sniff out even low levels of a pathogen in minutes. Here’s how it works. Read More 10/06/2020 • Press Release Visby Medical’s Personal PCR Receives Funding from National Institute of Health, RADx Program Visby Medical, an infectious disease diagnostic company, received funding from the National Institutes of Health as part of the organization’s Rapid Acceleration of Diagnostics (RADx) program, an initiative that aims to combat SARS-CoV-2 and increase national testing capacity for COVID-19. Read More 10/06/2020 • Article Personal PCR: Rapid, Reliable, and Prolific Personal PCR could one day become as common as the common cold. In the future, the device will deliver lab accurate results anywhere and to anyone — forever changing our relationship with diagnostics. Read More 09/16/2020 • Press Release Visby Medical’s Personal PCR Device Receives FDA Emergency Use Authorization for Moderate-Complexity Lab Environments Seven-year-old startup emerges from stealth mode, provides adaptable and rapid testing technology to frontline lab personnel fighting the pandemic Read More 09/16/2020 • Article Visby exits stealth to bring its Personal PCR Test to the fight against COVID-19 Now that Visby has received EUA for our Personal PCR Test to be deployed in moderate-complexity CLIA-certified labs, we’re taking it to the front line of the fight against COVID-19. Each device is personal to individual patients, with results delivered to a lab technician in less than 30 minutes. Read More 08/05/2020 • Press Release Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistance As appeared in NIH website 8/5/20 Read More Media Coverage On-the-go coronavirus test maker gets $10 million NIH contract to scale up production. Visby Medical Inc. emerged from stealth mode to secure emergency use authorization (EUA). Home Sexual Health Test COVID-19 Test About Us News FAQ Contact How to Buy Legal Careers Headquarters 3010 North First Street San Jose, CA 95134 Email info@visby.com ©2021 Visby Medical, Inc. All rights reserved. Visby Medical and the Visby Medical logo are registered trademarks of Visby Medical, Inc.